A Study on the Treatment of Parkinson's Disease With Autologous Neural Stem Cells
NCT03815071
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
Ips-nsc cells
Sponsor
Allife Medical Science and Technology Co., Ltd.
Collaborators
[object Object]
[object Object]
[object Object]